489 related articles for article (PubMed ID: 9023267)
21. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
Itzhak Y; Ali SF
Ann N Y Acad Sci; 1998 May; 844():245-51. PubMed ID: 9668682
[TBL] [Abstract][Full Text] [Related]
22. Prenatal ethanol exposure modifies [3H]MK-801 binding to NMDA receptors: spermidine and ifenprodil.
Honse Y; Randall PK; Leslie SW
Alcohol Clin Exp Res; 2003 Dec; 27(12):1993-2001. PubMed ID: 14691388
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.
Benavides J; Peny B; Allen J; Scatton B
J Pharmacol Exp Ther; 1992 Feb; 260(2):896-901. PubMed ID: 1310741
[TBL] [Abstract][Full Text] [Related]
24. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors.
Moebius FF; Bermoser K; Reiter RJ; Hanner M; Glossmann H
Biochemistry; 1996 Dec; 35(51):16871-8. PubMed ID: 8988026
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
Zhang XX; Bunney BS; Shi WX
Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of N-methyl-D-aspartate receptor-specific [(3)H]Ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes.
Grimwood S; Richards P; Murray F; Harrison N; Wingrove PB; Hutson PH
J Neurochem; 2000 Dec; 75(6):2455-63. PubMed ID: 11080197
[TBL] [Abstract][Full Text] [Related]
27. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons.
Tamura Y; Sato Y; Yokota T; Akaike A; Sasa M; Takaori S
J Pharmacol Exp Ther; 1993 May; 265(2):1017-25. PubMed ID: 8098757
[TBL] [Abstract][Full Text] [Related]
28. N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
Bonhaus DW; McNamara JO
Mol Pharmacol; 1988 Sep; 34(3):250-5. PubMed ID: 2843744
[TBL] [Abstract][Full Text] [Related]
29. Glycine regulation of the N-methyl-D-aspartate receptor-gated ion channel in hippocampal membranes.
Bonhaus DW; Yeh GC; Skaryak L; McNamara JO
Mol Pharmacol; 1989 Aug; 36(2):273-9. PubMed ID: 2475759
[TBL] [Abstract][Full Text] [Related]
30. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
31. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds.
Nankai M; Klarica M; Fage D; Carter C
Neurochem Int; 1996 Nov; 29(5):529-42. PubMed ID: 8939463
[TBL] [Abstract][Full Text] [Related]
32. Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
Casalotti SO; Kozikowski AP; Fauq A; Tückmantel W; Krueger KE
J Pharmacol Exp Ther; 1992 Jan; 260(1):21-8. PubMed ID: 1530974
[TBL] [Abstract][Full Text] [Related]
33. Effects of Agelenopsis aperta toxins on the N-methyl-D-aspartate receptor: polyamine-like and high-affinity antagonist actions.
Williams K
J Pharmacol Exp Ther; 1993 Jul; 266(1):231-6. PubMed ID: 7687289
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
36. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.
Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB
Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849
[TBL] [Abstract][Full Text] [Related]
37. Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding.
Yeh GC; Bonhaus DW; McNamara JO
Mol Pharmacol; 1990 Jul; 38(1):14-9. PubMed ID: 1695316
[TBL] [Abstract][Full Text] [Related]
38. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
Grimwood S; Moseley AM; Carling RW; Leeson PD; Foster AC
Mol Pharmacol; 1992 May; 41(5):923-30. PubMed ID: 1375318
[TBL] [Abstract][Full Text] [Related]
40. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
